TickerFacts.

Lisata Therapeutics, Inc. (LSTA): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2016-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$31.14M
Year ended 2016-12-31
+34.0%
3-year compound annual growth
+29.2%
5-year compound annual growth
$49.67M2010-12-31: $49.67M2011-12-31: $8.65M2012-12-31: $11.95M2013-12-31: $12.95M2014-12-31: $15.68M2015-12-31: $20.16M2016-12-31: $31.14M$31.14M
2010-12-31 Cost of Revenue (USD) 2016-12-31
Period endedCost of RevenueChange YoYSource filing
2016-12-31$31.14M+54.5%2017-03-17, From 2016-01-01
2015-12-31$20.16M+28.6%2017-03-17, From 2015-01-01
2014-12-31$15.68M+21.1%2016-03-15, From 2014-01-01
2013-12-31$12.95M+8.4%2016-03-15, From 2013-01-01
2012-12-31$11.95M+38.2%2015-03-02, From 2012-01-01
2011-12-31$8.65M-82.6%2013-03-11, From 2011-01-01
2010-12-31$49.67Mn/a2012-03-20, From 2010-01-01